OBJECTIVES: Although the prevalence of fluoroquinolone resistance among methicillin-resistant Staphylococcus aureus (MRSA) is known to be higher than in methicillin-susceptible S. aureus (MSSA), the reasons have never been identified. METHODS: We randomly selected 115 isolates of S. aureus collected from 10 different hospitals in Korea between June 2009 and May 2011. To investigate the difference in fluoroquinolone resistance mechanisms between MRSA and MSSA, we evaluated gyrA and parC mutations and the relative expression of the multidrug efflux pump genes norA, norB and norC. RESULTS: All 62 ciprofloxacin-resistant S. aureus had either gyrA or parC mutations. The S84L mutation of gyrA (59/62, 95.2%) and the S80F mutation of parC (61/62, 98.4%) were the most common. Fifty-eight (93.6%) strains had both the S84L mutation of gyrA and the S80F mutation of parC. Among the 115 isolates, norB overexpression was the most common, occurring in 49 (42.6%) strains. There were only two (1.7%) strains with norA overexpression and none with norC overexpression. Strains overexpressing norB were more common among ciprofloxacin-resistant S. aureus (33/62, 53.2%) than ciprofloxacin-susceptible S. aureus (16/53, 30.2%) (P = 0.013). When we analysed 62 ciprofloxacin-resistant S. aureus strains, those overexpressing norB were more common in ciprofloxacin-resistant MRSA (28/46, 60.9%) than in ciprofloxacin-resistant MSSA (5/16, 31.3%) (P = 0.041). CONCLUSIONS: Increased expression of norB can be a factor that contributes to ciprofloxacin resistance in MRSA strains.
OBJECTIVES: Although the prevalence of fluoroquinolone resistance among methicillin-resistant Staphylococcus aureus (MRSA) is known to be higher than in methicillin-susceptible S. aureus (MSSA), the reasons have never been identified. METHODS: We randomly selected 115 isolates of S. aureus collected from 10 different hospitals in Korea between June 2009 and May 2011. To investigate the difference in fluoroquinolone resistance mechanisms between MRSA and MSSA, we evaluated gyrA and parC mutations and the relative expression of the multidrug efflux pump genes norA, norB and norC. RESULTS: All 62 ciprofloxacin-resistant S. aureus had either gyrA or parC mutations. The S84L mutation of gyrA (59/62, 95.2%) and the S80F mutation of parC (61/62, 98.4%) were the most common. Fifty-eight (93.6%) strains had both the S84L mutation of gyrA and the S80F mutation of parC. Among the 115 isolates, norB overexpression was the most common, occurring in 49 (42.6%) strains. There were only two (1.7%) strains with norA overexpression and none with norC overexpression. Strains overexpressing norB were more common among ciprofloxacin-resistant S. aureus (33/62, 53.2%) than ciprofloxacin-susceptible S. aureus (16/53, 30.2%) (P = 0.013). When we analysed 62 ciprofloxacin-resistant S. aureus strains, those overexpressing norB were more common in ciprofloxacin-resistant MRSA (28/46, 60.9%) than in ciprofloxacin-resistant MSSA (5/16, 31.3%) (P = 0.041). CONCLUSIONS: Increased expression of norB can be a factor that contributes to ciprofloxacin resistance in MRSA strains.
Authors: Carmen E DeMarco; Laurel A Cushing; Emmanuel Frempong-Manso; Susan M Seo; Tinevimbo A A Jaravaza; Glenn W Kaatz Journal: Antimicrob Agents Chemother Date: 2007-06-18 Impact factor: 5.191
Authors: T S Naimi; K H LeDell; D J Boxrud; A V Groom; C D Steward; S K Johnson; J M Besser; C O'Boyle; R N Danila; J E Cheek; M T Osterholm; K A Moore; K E Smith Journal: Clin Infect Dis Date: 2001-09-05 Impact factor: 9.079
Authors: F J Schmitz; A C Fluit; D Hafner; A Beeck; M Perdikouli; M Boos; S Scheuring; J Verhoef; K Köhrer; C Von Eiff Journal: Antimicrob Agents Chemother Date: 2000-11 Impact factor: 5.191
Authors: Eu Suk Kim; Jin Su Song; Hye Jin Lee; Pyoeng Gyun Choe; Kyung Hwa Park; Jae Hyun Cho; Wan Beom Park; Sung-Han Kim; Ji-Hwan Bang; Dong-Min Kim; Kyoung Un Park; Sue Shin; Mi Suk Lee; Hee Jung Choi; Nam Joong Kim; Eui-Chong Kim; Myoung-Don Oh; Hong Bin Kim; Kang Won Choe Journal: J Antimicrob Chemother Date: 2007-09-20 Impact factor: 5.790
Authors: Valentin V Rybenkov; Helen I Zgurskaya; Chhandosee Ganguly; Inga V Leus; Zhen Zhang; Mohammad Moniruzzaman Journal: Chem Rev Date: 2021-02-17 Impact factor: 60.622
Authors: Thao Le Masters; Stephen Johnson; Patricio R Jeraldo; Kerryl E Greenwood-Quaintance; Scott A Cunningham; Matthew P Abdel; Nicholas Chia; Robin Patel Journal: J Mol Diagn Date: 2021-06-05 Impact factor: 5.341